A Neuprez S Coste E Rompen J M Crielaard J Y Reginster
10.1007/s00198-013-2437-z
Osteoporos Int
2014 Jan;25(1):393-5.
CC BY-NC
https://pubmed.ncbi.nlm.nih.gov/23835864/
Antibodies, Monoclonal, Humanized / adverse effects Bone Density Conservation Agents / adverse effects Mandibular Diseases / chemically induced Osteonecrosis / chemically induced Osteoporosis / drug therapy
Antibodies, Monoclonal, Humanized / adverse effects Bone Density Conservation Agents / adverse effects Mandibular Diseases / chemically induced Osteonecrosis / chemically induced Osteoporosis / drug therapy Case Reports Antibodies, Monoclonal, Humanized / therapeutic use Bone Density Conservation Agents / therapeutic use Denosumab Humans Male Mandibular Diseases / diagnostic imaging Mandibular Diseases / etiology Middle Aged Osteonecrosis / diagnostic imaging Osteonecrosis / etiology RANK Ligand / antagonists & inhibitors Tomography, X-Ray Computed Tooth Extraction / adverse effects Antibodies, Monoclonal, Humanized Bone Density Conservation Agents RANK Ligand Denosumab
PMC3889627
23835864
Osteonecrosis of the jaw in a male osteoporotic patient treated with denosumab
2014